The breakthrough isn't a new drug. It's understanding each person well enough to solve it.

Cardiovascular care has been built on population averages. Read an individual's biology precisely enough, down to their genetics and markers, and the right prevention, the right therapy, and the right dose become predictable, not trial and error. We're bringing that precision to every clinic.